I didn’t think it was working until I took the pic: 10 months minox 2.5 Dut 0.5 Is this regrowth? 11/16/2025
The user experienced hair regrowth after 10 months using Minoxidil, 2.5 mg Dutasteride, and 0.5 mg Finasteride. They switched from a compounded pill to Avodart capsules and plan to reassess their treatment after one year.
View this post in the Community →
Similar Community Posts Join
6 / 6 resultscommunity M30, month 2 of dutasteride and minoxidil
A user shared their two-month progress using dutasteride, minoxidil, ketoconazole shampoo, and tretinoin cream for hair loss, reporting no side effects and increased sex drive. Other users discussed their experiences with similar treatments, including finasteride and oral minoxidil, and debated the effectiveness of microneedling.
community Rate my regimen: 20yo/M looking for advice
A 20 year old male discussing his hair loss regimen, which includes using topical dutasteride, rogaine, RU58841, minoxidil and Avodart pills as well as scalp massage, stabbing head with steak knife, counting shed hairs under a hair net and sending them to a lab for analysis. Suggestions from other users include scalping method and switching to saw palmetto and zinc supplements.
community Guys using oral dut after multiple years of fin, how many gains did you have?
Switching from finasteride to dutasteride did not result in significant hair regrowth for most users, with some experiencing worsening hair conditions or side effects. Many users continue using minoxidil alongside these treatments.
community 1 year results - fin+min till August and then dut+min after that
The user experienced positive hair growth results using oral minoxidil and finasteride initially, then switched to dutasteride and higher-dose minoxidil. They plan to try topical minoxidil foam to improve the crown area and reported increased libido with dutasteride.
community On Fin 5 days a week and dut twice a week and still rapidly losing hair. HOW?? 9 months on fin!
A user using finasteride and dutasteride to treat hair loss, but still losing hair rapidly after stopping minoxidil. Replies suggest that the user should try oral minoxidil or switch to dutasteride for better results.
community No gains after 4 years of min and fin
User has seen no improvement after 4 years of using minoxidil and finasteride, and recently started dutasteride. Suggestions include adding oral minoxidil, microneedling, and considering a hair transplant.
Related Research
6 / 6 resultsresearch Treatment of Androgenetic Alopecia with Low Dose Oral Minoxidil Monotherapy Compared to Combination Therapy with Dutasteride or Finasteride
Low-dose oral minoxidil alone is effective for treating hair loss, but combining it with dutasteride or finasteride may offer better results.
research Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia
In this study, the authors reported that oral dutasteride at 0.5 mg/day showed a probable greater efficacy in treating male androgenetic alopecia compared to finasteride and minoxidil, but it may cause sexual dysfunction and neuropsychiatric side effects.
research Comparative Efficacy of Minoxidil and 5‐Alpha Reductase Inhibitors Monotherapy for Male Pattern Hair Loss: Network Meta‐Analysis Study of Current Empirical Evidence
This study found that among various treatments for male androgenetic alopecia, dutasteride 0.5 mg/day was the most effective option overall. Additionally, among FDA-approved treatments, topical minoxidil 5% was the most effective topical therapy, and finasteride 1 mg/day was the most effective oral therapy.
research Androgenetik Alopesi
This review discusses current treatment methods for managing androgenetic alopecia in men and women, but reports no new clinical results, highlighting the lack of a standard treatment guide.
research B‐ RAF , naevi and melanoma: a complex relationship
Male hair loss is mainly due to thinner hair, not less hair.
research Androgenetic Alopecia: What Works?
This review discusses the criteria for evaluating treatments for androgenetic alopecia and emphasizes the importance of shared decision-making, noting no treatment currently meets all desired criteria of efficacy, safety, affordability, and ease of use.